Abstract:The liver plays central homeostatic roles in metabolism and detoxification, and has a remarkable capacity to fully recover from injuries caused by the various insults to which it is constantly exposed. To fulfill these functions, the liver must maintain a specific size and so must regulate its cell numbers. It must also remove senescent, transformed, and/or injured cells that impair liver function and can lead to diseases such as cirrhosis and liver cancer. Despite their importance, however, the mechanisms governing liver size control and homeostasis have resisted delineation. The discovery of the Hippo intracellular signaling pathway and its downstream effectors, the transcriptional coactivators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ), has provided partial elucidation of these mechanisms. The Hippo-YAP/TAZ pathway is considered to be a cell's sensor of its immediate microenvironment and the cells that surround it, in that this pathway responds to changes in elements such as the ECM, cell-cell tension, and cell adhesion. Once triggered, Hippo signaling negatively regulates the binding of YAP/TAZ to transcription factors such as TEAD and Smad, controlling their ability to drive gene expression needed for cellular responses such as proliferation, survival, and stemness. Numerous KO mouse strains lacking YAP/TAZ, as well as transgenic mice showing YAP/TAZ hyperactivation, have been generated, and the effects of these mutations on liver development, size, regeneration, homeostasis, and tumorigenesis have been reported. In this review, I summarize the components and regulation of Hippo-YAP/TAZ signaling, and discuss this pathway in the context of liver physiology and pathology.

Hippo Signaling: Key Emerging Pathway in Cellular and Whole-Body Metabolism

Molecular mechanisms of the mammalian Hippo signaling pathway.

The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal

The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

Hippo signaling pathway in lung development, regeneration, and diseases.

The Hippo-YAP Pathway in Organ Size Control and Tumorigenesis: an Updated Version.

Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer

Regulation and Functions of the Hippo Pathway in Stemness and Differentiation.

The interplay between hippo signaling and mitochondrial metabolism: Implications for cellular homeostasis and disease

The Hippo Pathway in Biological Control and Cancer Development

The history and regulatory mechanism of the Hippo pathway

Hippo Signaling in the Immune System.

Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine

Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway

The Hippo signaling pathway: from multiple signals to the hallmarks of cancers

Structural Dissection of Hippo Signaling

Hippo-Yap Signaling Pathway: A New Paradigm for Cancer Therapy

New Horizons in Cancer Progression and Metastasis: Hippo Signaling Pathway

Physiological and pathological roles of the Hippo‐YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis

YAP/TAZ for cancer therapy: Opportunities and challenges (Review)

Hippo signalling in the liver: role in development, regeneration and disease